Enterococcus IVDs

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
11-11-2017

Saadav alates:

Cepheid Holdings Pty Ltd

Klass:

Class 3

Valmistatud:

Cepheid AB Rontgenvagen 5, Solna, SE-171 54 Sweden

Terapeutiline ala:

CT921 - Enterococcus IVDs

Näidustused:

The Cepheid Xpert vanA/vanB Assay performed in the GeneXpert System is a qualitative in vitro diagnostic test designed for rapid detection of vancomycin-resistance (vanA/vanB) genes from rectal and perianal swab specimens in patients at risk for intestinal colonization of vancomycin-resistant bacteria. The test utilizes automated real-time polymerase chain reaction (PCR) to detect the vanA and vanB genes that can be associated with vancomycin-resistant enterococci (VRE).

Volitamisolek:

A

Loa andmise kuupäev:

2013-04-04

Otsige selle tootega seotud teateid

Vaadake dokumentide ajalugu